Treatment with aripiprazole for hyperprolactinemia induced by pituitary microadenoma in a bipolar i disorder patient

Journal of Clinical Psychopharmacology

Volumn 30, Issue 1, 2010, Pages 78-80

  Chen, Shao Tsu ^a,b   Hsiao, Yi Lin ^a  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b TZU CHI UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLONAZEPAM; DULOXETINE; IMIPRAMINE; TRAZODONE;

ADULT; ANAMNESIS; BIPOLAR I DISORDER; CASE REPORT; CLINICAL FEATURE; DEPRESSION; FEMALE; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; INSOMNIA; LETTER; PRIORITY JOURNAL; URINE INCONTINENCE;

ADENOMA; ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; DOPAMINE ANTAGONISTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; PIPERAZINES; PITUITARY NEOPLASMS; QUINOLONES;

EID: 74549197640     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181ca3c85     Document Type: Letter

References (8)

1. Molitch ME. Medication-induced hyperprolactinaemia. Mayo Clin Proc. 2005;8:1050-1057.
2. Fleischhacker WW. Aripiprazole. Expert Opin Pharmacother. 2005;6:2091-2101.
3. Keck PE Jr, Marcus R, Tourkodimitris S, et al. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. Am J Psychiatry. 2003;160: 1651-1658.
4. Kupersmith MJ, Kleinberg D, Warren FA, et al. Growth of prolactinoma despite lowering of serum prolactin by bromocriptine. Neurosurgery. 1989;24: 417-423.
5. Lee BH, Kim YK, Park SH. Using aripiprazole to resolve antipsychotic-induced symptomatic hyperprolactinemia: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30:714-717.
6. Freeman B, Levy W, Gorman JM. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma. J Psychiatr Pract. 2007;13:120-124.
7. Sheldrick AJ, Grunder G. Aripiprazole reduces serum prolactin in a woman with prolactinoma and acute psychosis. Pharmacopsychiatry. 2008;41:160.
8. Zisook S, Kasckow JW, Golshan S, et al. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial. J Clin Psychiatry. 2009;70: 562-571.